Form 4: Quaker Chemical Corp Director Nandita Bakhshi Acquires Shares and Restricted Stock Units

Director Nandita Bakhshi acquired 277 shares of Quaker Chemical Corp common stock and 596 restricted stock units on July 31, 2024.

Summary

• Nandita Bakhshi, a director of Quaker Chemical Corp (KWR), reported changes in beneficial ownership on July 31, 2024.
• Bakhshi acquired 277 shares of common stock at a price of $180.225 per share, reflecting 75% of the director's prorated annual retainer paid in shares.
• Additionally, Bakhshi acquired 596 restricted stock units (RSUs) as part of her 2024 compensation under the Company's Long-Term Performance Incentive Plan.
• These RSUs vest 100% on May 31, 2025, and represent a contingent right to receive one share of KWR common stock each.
• Dividend equivalent rights accrue with respect to these RSUs when dividends are paid on KWR common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing insider transactions. The acquisition of shares and RSUs can be seen as a positive sign, but it's not a major event.

Positives

• The director's acquisition of shares demonstrates confidence in the company.
• The grant of restricted stock units aligns the director's interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of RSUs on May 31, 2025, suggests a continued relationship between the director and the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their alignment with shareholder interests.

Comparison to Industry Standards

• Director compensation packages often include a mix of cash, stock, and stock options to align their interests with shareholders.
• The vesting schedule of the restricted stock units is typical for such grants, encouraging long-term commitment.
• Comparing the size of the stock grant to those of directors at similar-sized chemical companies (e.g., Balchem, Stepan Company) would provide further context.

Stakeholder Impact

• Shareholders may view the director's stock acquisition as a positive signal.
• The compensation structure impacts the company's financials and is of interest to shareholders.

Key Dates